Skip to main content
. 2016 Jul 30;17(1):69. doi: 10.1186/s10194-016-0660-7

Table 2.

Detailed data of blood samplings in ECH patients: date and time, concentrations of PACAP-38 and therapyᅟ

Patients Date and time of inter-bout sampling Inter-bout PACAP-38 plasma level (fmol/ml) Last previous attacks (months ago) Date and time of ictal sampling Ictal PACAP-38 plasma level (fmol/ml) Beginning of bout period (days) and attacks (hours) before the ictal sampling Applied therapy
ECH-P1 06 June 2010 03:30 pm 22,70 3.0 15 May 2011 07:35 pm 31,00 Since 14 days, 3 h O 2, Sumariptan
ECH-P3 13 June 2010 01:15 pm 28,80 2.5 27 June 2010 07:55 pm 28,80 Since 2 days, 1.5 h O 2
ECH-P4 11 July 2010 01:15 pm 20,91 5.0 16 Aug 2010 08:00 am 26,00 Since 7 days, 2.5 h O 2 , Sumatriptan
ECH-P8 10 Sept 2010 08:30 am 24,40 2.0 15 Oct 2010 02:45 pm 27,30 Since 5 days, 2.5 h O 2
ECH-P9 19 Sept 2010 10:30 am 25,20 2.5 NSAIDs
ECH-P10 28 Nov 2010 01:00 pm 24,50 1.5 NSAIDs
ECH-P11 12 Jan 2011 10:00 am 22,20 3.0 NSAIDs
ECH-P12 29 Jan 2012 12:30 pm 23,37 3.5 11 Oct 2011 01:20 pm 29,1 Since 4 days, 2.0 h O 2 , Sumatriptan
ECH-P13 19 Dec 2011 09:00 am 25,06 2.5 O 2 , Sumatriptan, NSAIDs
Mean ± SD 24.1 ± 2.3 2.8 ± 1.0 28.4 ± 1.9 6.4 ± 4.6 days 2.3 ± 0.6 h